Clinical Trial Update: A Safety, Tolerability, and Immunogenicity Study of mRNA-1345 and mRNA-1365 in Participants Aged 5 Months to <24 Months [Phase 1]

View source ↗

Summary

Clinical trial update describing safety, tolerability, and immunogenicity assessment of Moderna’s mRNA vaccines mRNA-1345 and mRNA-1365 in infants and young chi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Human Metapneumovirus Infection
• Respiratory Syncytial Virus Infection

Drugs mentioned

• mRNA-1345
• mRNA-1365

Snippet

Sponsor: ModernaTX, Inc. | Conditions: Respiratory Syncytial Virus, Human Metapneumovirus | Phase 1 | Status: ACTIVE_NOT_RECRUITING